BMY vs INCY
Bristol Myers Squibb vs Incyte — AI-powered side-by-side comparison
| Metric | BMY | INCY |
|---|---|---|
| AI Score | 56 | 68 |
| Price | $65.30 | $119.47 |
| P/E Ratio | 14.39× | 14.70× |
| ROE | 0.4% | 0.2% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.7% | 0.9% |
| Debt / Equity | 1.93× | 0.01× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 79.6 | 49.5 |
| Beta | 0.235 | 0.758 |
| Expected Upside | +1.4% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMY Full Analysis
INCY Full Analysis